127034-35-9

Upstream product

• 127034-02-0 (E)-3-(N,N-dimethylaminophenyl)-1-(3,4,5-trimethoxyphenyl)-3-phenylprop-2-en-1-one 
• 100-10-7 4-dimethylamino-benzaldehyde 
• 13909-73-4 2',3',4'-trimethoxyacetophenone 
• 127034-25-7 (E)-4-(dimethylamino)-2′,3′,4′-trimethoxychalcone 

Relevant academic research and scientific papers

Controlling the growth of certain tumor tissue with chalcone derivatives

Certain chalcone derivatives are reported to inhibit the polymerization of tubulin to form microtubules and are therefore antimitotic agents which can be used to control the growth of tumor tissue and can be used as antigout agents.

Chalcones: A new class of antimitotic agents

A series of chalcones was evaluated as antimitotic agents. One of these, (E)-1-(2,5-dimethoxyphenyl)-3-[4-(dimethylamino)phenyl]-2-methyl-2-propen- 1-one) (73), was found to be an effective antimitotic agent at a concentration of 4 nM in an in vitro HeLa

Methods of treating gout with chalcone derivatives

Certain chalcone derivatives are reported to inhibit the polymerization of tubulin to form microtubules and are therefore antimitotic agents which can be used as antigout agents. The chalcone derivatives are also reported to inhibit the destruction of the

Method of treating multiple sclerosis with chalcone derivatives

Certain chalcone derivatives are reported to inhibit the polymerization of tubulin to form microtubules and are therefore antimitotic agents which can be used to control the growth of tumor tissue and can be used as antigout agents.